Brown, Lisle/Cummings’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Brown, Lisle/Cummings's AMGN Position: Q2 2026 in Review
Brown, Lisle/Cummings increased its Amgen (AMGN) stake by 0.33% in Q2 2026, buying an estimated $27.4K and bringing the position to 24,121 shares worth $8.73M. The position accounts for 1.96% of the portfolio, ranked #7.
Brown, Lisle/Cummings first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Brown, Lisle/Cummings held 24,121 shares of Amgen worth $8.73M as of Q2 2026.
- Brown, Lisle/Cummings bought 80 Amgen shares in Q2 2026, an estimated $27.4K.
- Amgen made up 1.96% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #7 holding.
- Brown, Lisle/Cummings first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.